The North Africa Non-Invasive Prenatal Testing Market Growth Accelerated by Rising Prevalence of Chromosomal Abnormalities

Non-invasive prenatal testing (NIPT) offers women safer and more reliable options for prenatal screening compared to traditional screening methods. It analyzes cell-free DNA from a simple blood draw of the mother to screen for common genetic conditions like Down syndrome with high accuracy. The rising cases of pregnancies affected by chromosomal abnormalities have boosted the demand for NIPT across North Africa.

The North Africa Non-Invasive Prenatal Testing Market is estimated to be valued at US$ 3805.83 Bn in 2024 and is expected to exhibit a CAGR of 6.9% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.

Market key trends:
The increased adoption of NIPT is mainly driven by the rising prevalence of chromosomal abnormalities during pregnancies across North Africa. According to WHO, the prevalence of Down syndrome is around 1 in 1000 live births in North Africa. NIPT helps identify such abnormalities at an early stage, allowing parents to make informed decisions. It has high detection rates of over 99% for common trisomies like trisomy 21, reducing the need for invasive diagnostic tests. As such abnormalities are becoming more common, NIPT is gaining popularity as the primary prenatal screening method in the region.

Segment Analysis
The North Africa non-invasive prenatal testing (NIPT) market is dominating by the screening and diagnostic tests segment. This segment accounts for the major share due to high adoption of advanced screening and diagnostic tests for prenatal genetic screening. Rapid technological advancements facilitating the availability of improved screening and diagnostic tests for prenatal screening has further driven the growth of this segment.

Key Takeaways
The North Africa non-invasive prenatal testing market size is expected to witness high growth during the forecast period. The North Africa Non-Invasive Prenatal Testing Market is estimated to be valued at US$ 3805.83 Bn in 2024 and is expected to exhibit a CAGR of 6.9% over the forecast period 2024 to 2031.

The Egypt non-invasive prenatal testing market is expected to witness the fastest growth over the forecast period. This is attributed to growing awareness about prenatal testing and availability of advanced healthcare facilities in the country.

Key players operating in the North Africa non-invasive prenatal testing (NIPT) market are Enraf-Nonius B.V., DJO Global, EMS Physio Ltd., Dynatronics Corporation, A. Algeo Limited, BTL Industries, Inc., HMS Medical Systems, Whitehall Manufacturing, Patterson Companies, Inc., and Isokinetics, Inc.

Get more insights on this topic: https://www.newsstatix.com/north-africa-non-invasive-prenatal-testing-market-share-and-opportunity-analysis/